KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Liabilities and Shareholders Equity (2016 - 2025)

Repligen (RGEN) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 4.24% to $2.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $11.6 billion, a 2.17% increase, with the full-year FY2025 number at $2.9 billion, up 4.24% from a year prior.
  • Liabilities and Shareholders Equity was $2.9 billion for Q4 2025 at Repligen, up from $2.9 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.9 billion in Q4 2025 to a low of $1.9 billion in Q1 2021.
  • A 5-year average of $2.6 billion and a median of $2.6 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 51.82% in 2021, then fell 0.05% in 2025.
  • Repligen's Liabilities and Shareholders Equity stood at $2.4 billion in 2021, then rose by 7.35% to $2.5 billion in 2022, then increased by 11.83% to $2.8 billion in 2023, then decreased by 0.05% to $2.8 billion in 2024, then increased by 4.24% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Liabilities and Shareholders Equity are $2.9 billion (Q4 2025), $2.9 billion (Q3 2025), and $2.9 billion (Q2 2025).